Načítá se...

Secukinumab in the Treatment of Plaque Psoriasis in Patients with Malignancy

Although available data are conflicting, psoriasis seems to be associated with an increased baseline risk of malignancy. In addition, some antipsoriatic systemic treatments have been associated with risk of malignancy. There is not enough data on the association of interleukin (IL)-17 and IL-23 inhi...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Case Rep Dermatol
Hlavní autor: Gambardella, Alessio
Médium: Artigo
Jazyk:Inglês
Vydáno: S. Karger AG 2019
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6816125/
https://ncbi.nlm.nih.gov/pubmed/31662733
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000501993
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!